Reported Reactions

Manufacturers

Device manufacturer, as written on reports

Medtronic Puerto Rico Operations Med-Rel: medical device reports filed with FDA

10,804 reports name it as the manufacturer of the device involved, 2006–2011.

10,804
reports naming it as manufacturer
0% of all MAUDE reports
0
reports, 12 months to August 2026
0 in the 12 months before
37.5%
classified as malfunction
62.3% across all reports
2.2%
classified as death, as reported
0.9% across all reports

10,804 medical device reports received by FDA give Medtronic Puerto Rico Operations Med-Rel as the manufacturer of the device involved, 0% of the MAUDE database, from June 2006 to October 2011. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.

0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (60.1%), malfunction (37.5%) and death (2.2%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands named most often

BrandDevice typeReportsLatest 12 monthsClassified as death
Paradigm Real-Time Insulin Infusion PumpPump, infusion, insulin, to be used with invasive glucose sensor1,38900.3%
Pump Mmt-722nas Prdgm Ins V2 2 Sk EnPump, infusion, insulin1,34102.6%
Paradigm Real-Time Revel Insulin Infusion PumpPump, infusion, insulin, to be used with invasive glucose sensor72300.6%
Pump Mmt-522nas Prdgm Ins V2 2 Sk EnPump, infusion, insulin69103.5%
Pump Mmt-722nab Prdgm Ins V2 2 Bl EnPump, infusion, insulin58802.1%
Pump Mmt-722nal Prdgm Ins V2 2 Cl En PrPump, infusion, insulin56902%
Pump Mmt-722nap Prdgm Ins V2 2 Pl EnPump, infusion, insulin52202.8%
Pump Mmt-522nal Prdgm Ins V2 2 Cl EnPump, infusion, insulin41900.8%
Rsvr Mmt-326a 10pk Prdgm 1 8ml 13lSyringe, piston37700.4%
Pump Mmt-522nab Prdgm Ins V2 2 Bl EnPump, infusion, insulin28801.7%
Pump Mmt-522nap Prdgm Ins V2 2 Pl EnPump, infusion, insulin27501.7%
Pump Mmt-715nas Prdgm Ins V2 1 Sk EnPump, infusion, insulin21005.1%
Rsvr Mmt-332a 10pk Prdgm 3cc 14lSyringe, piston20400.7%
Reservoir 1 8 MlPump, infusion18600.9%
Paradigm Insulin Infusion PumpPump, infusion, insulin16300.4%
Reservoir 3ccPump, infusion13203.6%
Reservoir 3mlPump, infusion9500.8%
Pump Mmt-515nas Prdgm Ins V2 1 Sk EnPump, infusion, insulin8805.2%
Pump Mmt-715nal Prdgm Ins V2 1 Cl EnPump, infusion, insulin7503.9%
Paradigm Real-Time Insulin Infusion Pump Mmt-722nasPump, infusion, insulin, to be used with invasive glucose sensor2781.5%
Paradigm Model Mmt-715 SmokePump, infusion, insulin2101.6%
Paradigm Real-Time Insulin Infusion Pump Mmt-522nasPump, infusion, insulin, to be used with invasive glucose sensor1503%
Paradigm Real-Time Insulin Infusion Pump Mmt-722nabPump, infusion, insulin, to be used with invasive glucose sensor1222.1%
Paradigm Real-Time Revel Insulin Infusion Pump Mmt-723nasPump, infusion, insulin, to be used with invasive glucose sensor10490.8%
Paradigm Real-Time Insulin Infusion Pump Mmt-722nallPump, infusion, insulin, to be used with invasive glucose sensor810.6%
Reservoir 1 8mlPump, infusion700.1%
Paradigm Real-Time Revel Insulin Infusion Pump Mmt-723nahPump, infusion, insulin, to be used with invasive glucose sensor500.5%
Pump Mmt-515lnas Prdgm Ins V2 1 Sk EnPump, infusion, insulin502.4%
Paradigm REAL-Time REVEL Insulin Infusion Pump MMT-723NABPump, infusion, insulin, to be used with invasive glucose sensor490.8%
Paradigm REAL-Time REVEL Insulin Infusion Pump MMT-723NAPPump, infusion, insulin, to be used with invasive glucose sensor4110.5%

Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Device types

Product codeDevice typeReportsShare
LZGPump, infusion, insulin6,01055.6%
MDSSensor, glucose, invasive3,55232.9%
FMFSyringe, piston5665.2%
FRNPump, infusion5334.9%
OYCPump, infusion, insulin, to be used with invasive glucose sensor1091%
CGAGlucose oxidase, glucose240.2%
LGZWarmer, thermal, infusion fluid30%
EZWStimulator, electrical, implantable, for incontinence20%
LGWStimulator, spinal-cord, totally implanted for pain relief20%
LKKPump, infusion, implanted, programmable10%

Reports by month, five years

011Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 0Jun 2022: 0Jul 2022: 0Aug 2022: 0Sep 2022: 0Oct 2022: 0Nov 2022: 0Dec 2022: 02023Jan 2023: 0Feb 2023: 0Mar 2023: 0Apr 2023: 0May 2023: 0Jun 2023: 0Jul 2023: 0Aug 2023: 0Sep 2023: 0Oct 2023: 0Nov 2023: 0Dec 2023: 02024Jan 2024: 0Feb 2024: 0Mar 2024: 0Apr 2024: 0May 2024: 0Jun 2024: 0Jul 2024: 0Aug 2024: 0Sep 2024: 0Oct 2024: 0Nov 2024: 0Dec 2024: 02025Jan 2025: 0Feb 2025: 0Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 0Aug 2025: 0Sep 2025: 0Oct 2025: 0Nov 2025: 0Dec 2025: 02026Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type

Death2.2%242
Injury60.1%6,494
Malfunction37.5%4,054
Other0%2
Not given0.1%12

Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.

Questions about Medtronic Puerto Rico Operations Med-Rel reports

How many FDA device reports name Medtronic Puerto Rico Operations Med-Rel as manufacturer?

10,804 reports through August 2026, 0 of them in the latest 12 months.

Which of its brands appear most often?

Paradigm Real-Time Insulin Infusion Pump (1,389), Pump Mmt-722nas Prdgm Ins V2 2 Sk En (1,341), Paradigm Real-Time Revel Insulin Infusion Pump (723), Pump Mmt-522nas Prdgm Ins V2 2 Sk En (691) and Pump Mmt-722nab Prdgm Ins V2 2 Bl En (588).

Which device types does it report on?

pump, infusion, insulin (55.6%), sensor, glucose, invasive (32.9%), syringe, piston (5.2%) and pump, infusion (4.9%).

Does a high count say something about the manufacturer?

Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.